Table 1.

Data sources consulted to complete the reporting template and scope of the reporting systems

Country	National shortage reporting system	Reporter	Drugs included in reporting system	National drug formulary for hospitals or community pharmacy consulted to complete reporting template
Belgium	Federal Agency for Medicines and Health Products (FAGG)	Marketing authorization holders	Drug for which unavailability cause a risk for public health and have no therapeutic alternative	Belgian Centre for Pharmacotherapeutic Information (BCFI)
	Farmaco-contingentering.be	Pharmacists	Products subjected to supply quota
The Netherlands	Farmanco.nl	Marketing authorization holders, wholesalers, pharmacists	Unlimited	Geneesmiddelenrepertorium.nl
England	Pharmaceutical Services Negotiation Committee (PSNC)	Pharmacists	Products for community pharmacy only	Eudrapharm
Italy	Italian Medicines Agency (AIFA)	Marketing authorization holders, health care providers, health departments, patients or associations	Unlimited	Italian Drug Formulary (AIFA)
				Eudrapharm
Germany	Federal Institute for Drugs and Medical Devices (Bfarm)	Marketing authorization holders	Products for treatment of threatening or serious diseases for which no alternatives are available	Federal Institute for Drugs and Medical Devices (Bfarm)
				Eudrapharm
Spain	Spanish Agency for Medicines and Health Products (aemps)	Marketing authorization holders or health authorities of autonomous communities	Unlimited	Spanish Agency for Medicines and Health Products (aemps)
France	National Agency for Safety of Drugs and Health Products (ansm)	Pharmacists and hospitals	Drug for which unavailability cause a risk for public health and have no therapeutic alternative	National Agency for Safety of Drugs and Health Products (ansm)